NEKTAR THERAPEUTICS Quarterly Debt-to-equity in % from Q3 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Nektar Therapeutics quarterly Debt-to-equity history and growth rate from Q3 2011 to Q3 2024.
  • Nektar Therapeutics Debt-to-equity for the quarter ending September 30, 2024 was 274 %, a 112% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 274 +145 +112% Sep 30, 2024
Q2 2024 218 +109 +99.3% Jun 30, 2024
Q1 2024 182 +84.7 +87.1% Mar 31, 2024
Q4 2023 160 +77.4 +93.2% Dec 31, 2023
Q3 2023 129 +53.8 +71.5% Sep 30, 2023
Q2 2023 109 +41.4 +60.8% Jun 30, 2023
Q1 2023 97.2 +37.2 +62% Mar 31, 2023
Q4 2022 83 +28.5 +52.4% Dec 31, 2022
Q3 2022 75.3 +26 +52.6% Sep 30, 2022
Q2 2022 68 +26.4 +63.3% Jun 30, 2022
Q1 2022 60 +24.4 +68.7% Mar 31, 2022
Q4 2021 54.5 +18.5 +51.2% Dec 31, 2021
Q3 2021 49.4 +13.5 +37.7% Sep 30, 2021
Q2 2021 41.7 +3.07 +7.96% Jun 30, 2021
Q1 2021 35.6 -4.55 -11.3% Mar 31, 2021
Q4 2020 36 -0.91 -2.46% Dec 31, 2020
Q3 2020 35.9 +2.92 +8.86% Sep 30, 2020
Q2 2020 38.6 +9.22 +31.4% Jun 30, 2020
Q1 2020 40.1 +13.3 +49.6% Mar 31, 2020
Q4 2019 36.9 +4.08 +12.4% Dec 31, 2019
Q3 2019 33 -13.7 -29.4% Sep 30, 2019
Q2 2019 29.4 -57.2 -66.1% Jun 30, 2019
Q1 2019 26.8 -756 -96.6% Mar 31, 2019
Q4 2018 32.9 -819 -96.1% Dec 31, 2018
Q3 2018 46.7 -831 -94.7% Sep 30, 2018
Q2 2018 86.6 -2.73K -96.9% Jun 30, 2018
Q1 2018 783 -6.82K -89.7% Mar 31, 2018
Q4 2017 852 +11.1K Dec 31, 2017
Q3 2017 878 +2.84K Sep 30, 2017
Q2 2017 2.82K -29K -91.1% Jun 30, 2017
Q1 2017 7.6K +5.34K +236% Mar 31, 2017
Q4 2016 -10.2K -11.3K -1024% Dec 31, 2016
Q3 2016 -1.96K -2.84K -322% Sep 30, 2016
Q2 2016 31.8K +31K +3618% Jun 30, 2016
Q1 2016 2.26K +851 +60.3% Mar 31, 2016
Q4 2015 1.11K -3.7K -77% Dec 31, 2015
Q3 2015 883 +3.12K Sep 30, 2015
Q2 2015 857 +1.92K Jun 30, 2015
Q1 2015 1.41K +2.41K Mar 31, 2015
Q4 2014 4.81K +5.82K Dec 31, 2014
Q3 2014 -2.24K +1.62K +42% Sep 30, 2014
Q2 2014 -1.06K -2.88K -158% Jun 30, 2014
Q1 2014 -1K -1.69K -245% Mar 31, 2014
Q4 2013 -1.02K -1.47K -326% Dec 31, 2013
Q3 2013 -3.85K -4.18K -1278% Sep 30, 2013
Q2 2013 1.82K +1.55K +593% Jun 30, 2013
Q1 2013 692 +481 +228% Mar 31, 2013
Q4 2012 450 +276 +159% Dec 31, 2012
Q3 2012 327 +129 +65.2% Sep 30, 2012
Q2 2012 262 Jun 30, 2012
Q1 2012 211 Mar 31, 2012
Q4 2011 174 Dec 31, 2011
Q3 2011 198 Sep 30, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.